The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.
 
Helen Mackay
Honoraria - AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - Eisai; GlaxoSmithKline; Merck
 
Andrew B. Nixon
Consulting or Advisory Role - AdjuVolt; Leap Therapeutics; Promega
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Genmab (Inst); HTG Molecular Diagnostics (Inst); medpacto (Inst); Promega (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
 
Danielle Enserro
No Relationships to Disclose
 
David Bender
No Relationships to Disclose
 
BJ Rimel
Honoraria - Genentech
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Deep 6 AI; Genentech/Roche; GlaxoSmithKline; Merck; Tesaro
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline/Tesaro; GOG partners; Roche/Genentech; Seagen; Tesaro
Research Funding - GlaxoSmithKline/Tesaro (Inst)
 
Debra L. Richardson
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Immunogen; Mersana
Research Funding - Aravive (Inst); Arch Oncology (Inst); ArQule (Inst); AstraZeneca (Inst); Celsion (Inst); Clovis Oncology (Inst); Deciphera (Inst); Five Prime Therapeutics (Inst); Fujifilm (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Hookipa Biotech (Inst); Innovent Biologics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Mersana (Inst); Plexxikon (Inst); Roche (Inst); Shattuck Labs (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
 
Laura L. Holman
No Relationships to Disclose
 
Nitya Alluri
No Relationships to Disclose
 
Cara Amanda Mathews
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Deciphera (Inst); EMD Serono (Inst); Laekna Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Seagen (Inst); Syros Pharmaceuticals (Inst); Tesaro/GSK (Inst)
 
Ruchi Garg
Employment - Witty Health
Leadership - MyCareGorithm
Stock and Other Ownership Interests - Doctorpedia; Witty Health
Honoraria - Doctorpedia; MyCareGorithm
Consulting or Advisory Role - Eisai; ImmunoGen
Speakers' Bureau - AstraZeneca
Expert Testimony - Greenberg Traurig
Travel, Accommodations, Expenses - Eisai
 
Sarah Gill
No Relationships to Disclose
 
Daniela Matei
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Merck; Seagen
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; Merck; Seagen
Research Funding - Abbvie (Inst); Merck; PinotBio (Inst)
 
Charles A. Leath
Consulting or Advisory Role - GlaxoSmithKline; GOG Foundation; Immunogen; Merck; Natera; Seagen
Research Funding - Abbvie (Inst); Agenus (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Celsion (Inst); Corcept Therapeutics (Inst); Immunogen (Inst); Merck (Inst); Rubius Therapeutics (Inst); Seagen (Inst); Tesaro (Inst)
 
Floor Jenniskens Backes
Consulting or Advisory Role - Abbott Diagnostics (I); Agenus; Agenus; AstraZeneca; Clovis Oncology; CMR Institute; Eisai; GlaxoSmithKline; Immunogen; Merck; Myriad Genetics; natera (Inst)
Research Funding - Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate (for writing a chapter)
 
Aimee Fleury
No Relationships to Disclose
 
Elizabeth M. Swisher
Leadership - IDEAYA Biosciences
Other Relationship - Novartis